Matches in Nanopublications for { ?s ?p "[Thus, targeting multiple metabolic stress pathways including the LKB1/AMPK pathway enhances lovastatin's ability to synergize with gefitinib in SCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP719495.RAajlB9KitY5Gz3NRiqUiCwh_g76cdqX3yT14x3WkRckc130_assertion description "[Thus, targeting multiple metabolic stress pathways including the LKB1/AMPK pathway enhances lovastatin's ability to synergize with gefitinib in SCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719495.RAajlB9KitY5Gz3NRiqUiCwh_g76cdqX3yT14x3WkRckc130_provenance.
- assertion description "[Thus, targeting multiple metabolic stress pathways including the LKB1/AMPK pathway enhances lovastatin's ability to synergize with gefitinib in SCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_assertion description "[Thus, targeting multiple metabolic stress pathways including the LKB1/AMPK pathway enhances lovastatin's ability to synergize with gefitinib in SCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017447.RAn6B6usF7XwXIHvW2huAYAyTy_nQ13DtYy5AwqNj6oxE130_provenance.